Share
6,834 Posts.
lightbulb Created with Sketch. 383
clock Created with Sketch. 16/03/17
10:07
Share
Originally posted by ds
↑
Paul is absolutely with PYC and is leading the science (yes the team is about 20-25 people I think). Within the TKI they have access to equipment that is well out of the reach of a biotech the size of PYC and a lot of their cost is able to go through R&D rebates. The recent announcements about Paul shares 'should' have been expected as they are all part of the mechanisms approved last year and the changes to his title/role. The blandness of regulatory announcements often provide confusion and I have suggested they put an explanatory cover sheet next time - blame the company secretary if you want someone to blame but they are just doing their job.
Expand
I will take my self, my secretary and hopefully my wife to PYC Adel presentation. They all seem to be invested in this stock, my sec even found it herself..... Keep up the good work ds, by that I mean rare but informative posts. It means you are conquering your disease...(well, one of them..lol)..
(20min delay)